Concept of Openness in the Health Commons: Engaging Global Stakeholders in Technology Development for Malaria January 2013
Open Innovation Crossing Sectors and Geographies December 2012
Presentation: Engaging Stakeholders for Global Health Innovation Capacity Development November 2012
The Lilly-NCD Partnership-Open Innovation Addressing the Burden of Non-Communicable Diseases in Developing Nations March 2012
Public Partnerships for Malaria-Engaging Stakeholders Within and on the Periphery of the Health Commons March 2012
The Ascend Research Network—An Open Innovation Strategy to Build Biopharma Research Capacity in Developing Nations March 2012
South Asia Network for Chronic Disease in India-Engaging in Open Innnovation, Research Capacity, and Policy Development March 2012
Astra Zeneca Enabling Product Development at the Bottom of the Pyramid;Pfizer's Open Innovation Strategy in Asia December 2011
Open Source Drug Discovery (OSDD) Collaborative Innovation November 2011 Learning from open innovation for neglected diseases
Networked Drug Discovery; Open Innovation Targeting the Bottom of the Pyramid August 2011
CRO-PPP Collaborations: Models of Open Innovation at the Bottom of the Pyramid Understanding Open Innovation Models for the Product Development Partnerships (PDP) Consortium July 2011
Open Innovation Case Study: Novartis Institutes for Biomedical Research July 2011
Open Innovation Case Study: Pfizer's Centers for Therapeutic Innovation April 2011
Open Innovation Case Study: GSK's Centres for External Drug Discovery April 2011
Contact us at info@bioendeavor.net to participate in our case study development. We are actively seeking both open innovation experts and organizations interested in profiling their open innovation business model development.
